Low dose IL-2 for potentiation of immunity
US6921530B1 · kind B1 · utility
1Cited by
8References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 22, 2000 |
| Grant date | Jul 26, 2005 |
| Priority date | — |
| Expiry date | Jun 27, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Low doses of IL-2 are administered to potentiate an immune response after antiviral treatment. IL-2 is also administered in conjunction with immunotherapy to enhance the immune response to infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.